Cellular and humoral responses after second and third SARS-CoV-2 vaccinations in patients with autoimmune diseases treated with rituximab: specific T cell immunity remains longer and plays a protective role against SARS-CoV-2 reinfections

BackgroundHumoral and cellular immune responses are known to be crucial for patients to recover from COVID-19 and to protect them against SARS-CoV-2 reinfection once infected or vaccinated.ObjectivesThis study aimed to investigate humoral and T cell responses to SARS-CoV-2 vaccination in patients wi...

Full description

Bibliographic Details

Published in:	Frontiers in Immunology
Main Authors:	Natalia Egri, Hugo Calderón, Robert Martinez, Mario Vazquez, Verónica Gómez-Caverzaschi, Mariona Pascal, Olga Araújo, Manel Juan, Europa Azucena González-Navarro, José Hernández-Rodríguez
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-04-01
Subjects:	COVID - 19 SARS-CoV-2 vaccines humoral response cellular response rituximab anti CD-20
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1146841/full